期刊
NEUROLOGICAL SCIENCES
卷 39, 期 8, 页码 1423-1430出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-018-3442-y
关键词
Relapsing-remitting multiple sclerosis; Beta interferon; Glatiramer acetate; Oligoclonal M bands
To study the efficacy of interferon beta (IFN beta) and glatiramer acetate (GA) related to the presence of oligoclonal M bands (OCMB) in the cerebrospinal fluid in relapsing-remitting multiple sclerosis (RRMS). This is an observational, multicenter and retrospective study with prospectively collected data of patients that started treatment with IFN beta or GA. Treatment decision was made blinded to the OCMB status. Time to first attack after starting therapy was compared by using Kaplan-Meier curves, and adjustment by Cox regression analysis was performed. Two hundred and fifty-six patients entered in the study (141-55% received IFN beta; 115-45% received GA). After a mean follow-up of 41 and 65 months, 54.7% of patients remained free from further attacks (RF). The proportion of RF patients was higher in the GA group than in the IFN beta group (72.2 vs. 40.4%, p < 0.001). The IFN beta patients with OCMB+ presented the poorest response, 31.3% RF vs. 48.1% in IFN beta without OCMB, p = 0.03. OCMB in CSF could be a biomarker of treatment response in multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据